This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (74)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Oncology  • Colon Cancer  • Randomized Controlled Trial  • Gastroenterology  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Andrew T. Chan, MD, MPH; Edward L. Giovannucci, MD, ScD; Jeffrey A. Meyerhardt, MD, MPH; Eva S. Schernhammer, MD, DrPH; Gary C. Curhan, MD, ScD; Charles S. Fuchs, MD, MPH

JAMA. 2005;294:914-923.

Context  Randomized trials of short-term aspirin use for prevention of recurrent colorectal adenoma have provided compelling evidence of a causal relationship between aspirin and colorectal neoplasia. However, data on long-term risk of colorectal cancer according to dose, timing, or duration of therapy with aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) remain limited.

Objective  To examine the influence of aspirin and NSAIDs in prevention of colorectal cancer.

Design, Setting, and Participants  Prospective cohort study of 82 911 women enrolled in the Nurses’ Health Study providing data on medication use biennially since 1980 and followed up through June 1, 2000.

Main Outcome Measure  Incident colorectal cancer.

Results  Over a 20-year period, we documented 962 cases of colorectal cancer. Among women who regularly used aspirin (2 standard [325-mg] tablets per week), the multivariate relative risk (RR) for colorectal cancer was 0.77 (95% confidence interval [CI], 0.67-0.88) compared with nonregular users. However, significant risk reduction was not observed until more than 10 years of use (P.001 for trend). The benefit appeared related to dose: compared with women who reported no use, the multivariate RRs for cancer were 1.10 (95% CI, 0.92-1.31) for women who used 0.5 to 1.5 standard aspirin tablets per week, 0.89 (95% CI, 0.73-1.10) for 2 to 5 aspirin per week, 0.78 (95% CI, 0.62-0.97) for 6 to 14 aspirin per week, and 0.68 (95% CI, 0.49-0.95) for more than 14 aspirin per week (P<.001 for trend). Notably, women who used more than 14 aspirin per week for longer than 10 years in the past had a multivariate RR for cancer of 0.47 (95% CI, 0.31-0.71). A similar dose-response relationship was found for nonaspirin NSAIDs (P = .007 for trend). The incidence of reported major gastrointestinal bleeding events per 1000 person-years also appeared to be dose-related: 0.77 among women who denied any aspirin use; 1.07 for 0.5 to 1.5 standard aspirin tablets per week; 1.07 for 2 to 5 aspirin per week; 1.40 for 6 to 14 aspirin per week; and 1.57 for more than 14 aspirin per week.

Conclusions  Regular, long-term aspirin use reduces risk of colorectal cancer. Nonaspirin NSAIDs appear to have a similar effect. However, a significant benefit of aspirin is not apparent until more than a decade of use, with maximal risk reduction at doses greater than 14 tablets per week. These results suggest that optimal chemoprevention for colorectal cancer requires long-term use of aspirin doses substantially higher than those recommended for prevention of cardiovascular disease, but the dose-related risk of gastrointestinal bleeding must also be considered.

Author Affiliations: Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School (Dr Chan), Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School (Drs Chan, Giovannucci, Schernhammer, Curhan, and Fuchs), Cancer Epidemiology Program, Dana-Farber/Harvard Cancer Center (Drs Giovannucci, Meyerhardt, and Fuchs), Departments of Epidemiology (Drs Giovannucci and Curhan) and Nutrition (Dr Giovannucci), Harvard School of Public Health, and Department of Medical Oncology, Dana-Farber Cancer Institute (Drs Meyerhardt and Fuchs), Boston, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Long-term Use of Aspirin and Risk of Colorectal Cancer
Gregory C. Vachon
JAMA. 2005;294(24):3090.
EXTRACT | FULL TEXT  

Long-term Use of Aspirin and Risk of Colorectal Cancer—Reply
Andrew T. Chan and Charles S. Fuchs
JAMA. 2005;294(24):3090-3091.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Nonsteroidal Antiinflammatory Agents and Incidence of Ovarian Cancer in 2 Large Prospective Cohorts
Pinheiro et al.
Am J Epidemiol 2009;169:1378-1387.
ABSTRACT | FULL TEXT  

Lupus and cancer
Gayed et al.
Lupus 2009;18:479-485.
ABSTRACT  

Nonsteroidal Anti-inflammatory Drug Use After 3 Years of Aspirin Use and Colorectal Adenoma Risk: Observational Follow-up of a Randomized Study
Grau et al.
JNCI J Natl Cancer Inst 2009;101:267-276.
ABSTRACT | FULL TEXT  

Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Cole et al.
JNCI J Natl Cancer Inst 2009;101:256-266.
ABSTRACT | FULL TEXT  

Dietary Intake of {omega}-6 and {omega}-3 Fatty Acids and Risk of Colorectal Cancer in a Prospective Cohort of U.S. Men and Women
Daniel et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:516-525.
ABSTRACT | FULL TEXT  

Use of Aspirin, Other Nonsteroidal Anti-inflammatory Drugs, and Acetaminophen and Risk of Breast Cancer Among Premenopausal Women in the Nurses' Health Study II
Eliassen et al.
Arch Intern Med 2009;169:115-121.
ABSTRACT | FULL TEXT  

Use of Aspirin, Other Nonsteroidal Anti-inflammatory Drugs, and Acetaminophen and Risk of Breast Cancer Among Premenopausal Women in the Nurses' Health Study II--Invited Commentary
Kakarala and Brenner
Arch Intern Med 2009;169:121-121.
FULL TEXT  

Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint
Jankowski and Hunt
Cancer Epidemiol. Biomarkers Prev. 2008;17:1858-1861.
ABSTRACT | FULL TEXT  

Conditional Loss of Uterine Pten Unfailingly and Rapidly Induces Endometrial Cancer in Mice
Daikoku et al.
Cancer Res. 2008;68:5619-5627.
ABSTRACT | FULL TEXT  

Aspirin is Clinically Effective in Chemoprevention of Colorectal Neoplasia: Point
Leshno et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1558-1561.
FULL TEXT  

Aspirin Sensitizes Cancer Cells to TRAIL-Induced Apoptosis by Reducing Survivin Levels
Lu et al.
Clin. Cancer Res. 2008;14:3168-3176.
ABSTRACT | FULL TEXT  

Generalizability of the Results of Randomized Trials
Weiss et al.
Arch Intern Med 2008;168:133-135.
FULL TEXT  

Epidemiologic Musing on Statin Drugs in the Prevention of Advanced Prostate Cancer
Platz
Cancer Epidemiol. Biomarkers Prev. 2007;16:2175-2180.
FULL TEXT  

Commentary: Aspirin and cancer prevention
Kune
Int J Epidemiol 2007;0:dym194v1-dym194.
FULL TEXT  

Commentary: Preventing colorectal cancer with aspirin what next?
Logan
Int J Epidemiol 2007;0:dym204v1-dym204.
FULL TEXT  

Validity of Self-Reported Endoscopies of the Large Bowel and Implications for Estimates of Colorectal Cancer Risk
Hoffmeister et al.
Am J Epidemiol 2007;166:130-136.
ABSTRACT | FULL TEXT  

Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality
Bardia et al.
JNCI J Natl Cancer Inst 2007;99:881-889.
ABSTRACT | FULL TEXT  

Extracellular Signal-Regulated Kinase Is a Target of Cyclooxygenase-1-Peroxisome Proliferator-Activated Receptor-{delta} Signaling in Epithelial Ovarian Cancer
Daikoku et al.
Cancer Res. 2007;67:5285-5292.
ABSTRACT | FULL TEXT  

Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2
Chan et al.
NEJM 2007;356:2131-2142.
ABSTRACT | FULL TEXT  

Long-term Aspirin Use and Mortality in Women
Chan et al.
Arch Intern Med 2007;167:562-572.
ABSTRACT | FULL TEXT  

Colitis and Colitis-Associated Cancer Are Exacerbated in Mice Deficient for Tumor Protein 53-Induced Nuclear Protein 1
Gommeaux et al.
Mol. Cell. Biol. 2007;27:2215-2228.
ABSTRACT | FULL TEXT  

Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force*
ANN INTERN MED 2007;146:361-364.
ABSTRACT | FULL TEXT  

The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Dube et al.
ANN INTERN MED 2007;146:365-375.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Rostom et al.
ANN INTERN MED 2007;146:376-389.
ABSTRACT | FULL TEXT  

Blood Levels of Long-Chain Polyunsaturated Fatty Acids, Aspirin, and the Risk of Colorectal Cancer
Hall et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:314-321.
ABSTRACT | FULL TEXT  

Statins and the Risk of Lung, Breast, and Colorectal Cancer in the Elderly
Setoguchi et al.
Circulation 2007;115:27-33.
ABSTRACT | FULL TEXT  

Aspirin and Nonsteroidal Anti-inflammatory Drug Use and Risk of Pancreatic Cancer: A Meta-analysis
Larsson et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2561-2564.
ABSTRACT | FULL TEXT  

The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women
Allison et al.
Am J Epidemiol 2006;164:567-575.
ABSTRACT | FULL TEXT  

Risks and benefits of celecoxib to prevent recurrent adenomas.
Psaty and Potter
NEJM 2006;355:950-952.
FULL TEXT  

Update in Gastroenterology and Hepatology
Greenberger and Sharma
ANN INTERN MED 2006;145:294-298.
FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence.
Anderson et al.
Cancer Res. 2006;66:4975-4982.
ABSTRACT | FULL TEXT  

Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
Chan et al.
Circulation 2006;113:1578-1587.
ABSTRACT | FULL TEXT  

Low dose aspirin did not prevent cancer in healthy women
Rees Willett
Evid. Based Med. 2006;11:10-10.
FULL TEXT  

Vitamin E did not prevent cardiovascular disease and cancer in healthy women
Rees Willett
Evid. Based Med. 2006;11:11-11.
FULL TEXT  

JournalScan
Gut 2006;55:114-114.
FULL TEXT  

Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening--A Report From the American Society of Clinical Oncology
Herbst et al.
JCO 2006;24:190-205.
ABSTRACT | FULL TEXT  

Long-term Use of Aspirin and Risk of Colorectal Cancer
Vachon
JAMA 2005;294:3090-3090.
FULL TEXT  

More About Aspirin, NSAIDs, and Colorectal Cancer
JWatch Gastroenterology 2005;2005:2-2.
FULL TEXT  

What's new in the other general journals
Martyn
BMJ 2005;331:537-538.
FULL TEXT  

Aspirin, NSAIDs, and Colorectal Cancer
JWatch General 2005;2005:4-4.
FULL TEXT